This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License
Regulus Therapeutics Inc. or Regulus (Nasdaq: RGLS) is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals.
| Property | Value |
|---|---|
| dbo:abstract |
|
| dbo:foundingYear |
|
| dbo:industry | |
| dbo:location | |
| dbo:numberOfEmployees |
|
| dbo:wikiPageExternalLink | |
| dbo:wikiPageID |
|
| dbo:wikiPageLength |
|
| dbo:wikiPageRevisionID |
|
| dbo:wikiPageWikiLink | |
| dbp:foundation |
|
| dbp:homepage | |
| dbp:industry | |
| dbp:keyPeople |
|
| dbp:location |
|
| dbp:name |
|
| dbp:numEmployees |
|
| dbp:products |
|
| dbp:tradedAs |
|
| dbp:type |
|
| dbp:wikiPageUsesTemplate | |
| dcterms:subject | |
| schema:sameAs | |
| rdf:type |
|
| rdfs:comment |
|
| rdfs:label |
|
| owl:sameAs | |
| prov:wasDerivedFrom | |
| foaf:homepage | |
| foaf:isPrimaryTopicOf | |
| foaf:name |
|
| is dbo:wikiPageRedirects of | |
| is dbo:wikiPageWikiLink of | |
| is foaf:primaryTopic of |